
AttackMS
13 posts

AttackMS
@AttackMS_trial
Testing the safety and efficacy of natalizumab very early in MS. Evidence suggests this will give MS patients a better long-term outcome.



🔥 The #BartsMSNavigator Now on the @NHSBartsHealth website: bartshealth.nhs.uk/download.cfm?v… Thank you all #Team11D, and particularly @AndreaStennett @Kimberley_AP @joelamathews👏 A #BartsMS #Navigator multiple-sclerosis-research.org/2023/05/a-bart… @the_MSBlog



Let's get #AttackMS trending @AttackMS_trial Highly effective treatment trial within 14 days of first symptom(s) Contact bartshealth.attackms@nhs.net from *anywhere* in the #UK Ask your doctor @StGeorgesTrust @ChelwestFT @NHSBartsHealth @Wendybird2012 @themsguide @RachelHorne19

📢#AttackMS If rapid access pathways are axed, the goal of living with #MS but #NotFeelMS is under threat @AttackMS_trial: Symptoms suggestive of MS within past 14 days? Up to 45 years old? Contact bartshealth.attackms@nhs.net @ChelwestFT @StGeorgesTrust @shiftms @NHSBartsHealth






